A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myeloma
JR Berenson, JD Hilger, O Yellin, RV Boccia… - Annals of …, 2014 - Springer
Panobinostat is a histone deacetylase inhibitor that has shown synergistic preclinical anti-
myeloma activity when combined with other agents, recently exhibiting synergy with the …
myeloma activity when combined with other agents, recently exhibiting synergy with the …
[HTML][HTML] Thalidomide dithiocarbamate and dithioate derivatives induce apoptosis through inhibition of histone deacetylases and induction of caspases
MAH Zahran, AM Gamal-Eldeen… - Journal of Genetic …, 2014 - Elsevier
Anti-cancer effect and mechanism of cell death were investigated in a battery of five
thalidomide analogs containing one sulfur atom 2 or two sulfur atoms 3–6 and were …
thalidomide analogs containing one sulfur atom 2 or two sulfur atoms 3–6 and were …
Capturing Alloreactivity in Multiple Myeloma
G Cook - Journal-Capturing Alloreactivity in Multiple Myeloma - touchoncology.com
Overview Allogeneic stem cell transplantation (alloSCT) has been utilised in the
management of both malignant and non-malignant haematological disorders for several …
management of both malignant and non-malignant haematological disorders for several …